. La-crainte-d, en insistant sur leur survenue potentielle lors de la prescription, est une raison fréquemment avancée par les médecins pour justifier une information incomplète (113,115,119) Néanmoins, une étude conclut que l'information des patients avant de débuter un traitement n'entraine pas d'augmentation d'incidence des évènements indésirables (120) Ses auteurs affirment que l'effet nocebo ne doit pas être une raison pour le médecin de ne pas avertir ses patients des effets secondaires possibles de ses prescriptions, autre travail va dans ce sens en affirmant que la délivrance d'une faible information augmente le risque iatrogène

U. Manquement-au-devoir-d, information peut entraîner le praticien devant la juridiction civile et ordinale Cette obligation est régie par les articles 34 à 36 du code de déontologie médicale et la loi du 4 mars 2002 (62) Le médecin doit à son patient une information claire, p.6

L. Orriols, Santé et insécurité routière : influence de la consommation de médicaments (Étude CESIR-A) [Internet], Disponible sur, 2010.

L. Orriols, B. Delorme, B. Gadegbeku, A. Tricotel, B. Contrand et al., Prescription Medicines and the Risk of Road Traffic Crashes: A French Registry-Based Study, PLoS Medicine, vol.30, issue.11, p.1000366, 2010.
DOI : 10.1371/journal.pmed.1000366.t007

URL : https://hal.archives-ouvertes.fr/inserm-00700891

. Observatoire-de-la-médecine-générale, Top 50 des Résultats de Consultation pour l'année, Disponible sur, 2009.

F. Raineri, P. Arnould, A. Malouli, G. Hebbrecht, and D. Duhot, Analyse de la prescription des antalgiques de palier??II en m??decine g??n??rale. Observatoire de la m??decine g??n??rale ??? 2007???? 2009, Douleurs : Evaluation - Diagnostic - Traitement, vol.12, issue.2, pp.72-81, 2007.
DOI : 10.1016/j.douler.2011.01.010

M. Leong, B. Murnion, and P. Haber, Examination of opioid prescribing in Australia from 1992 to 2007, Internal Medicine Journal, vol.33, issue.10, pp.676-681, 1992.
DOI : 10.1111/j.1445-5994.2009.01982.x

T. Clausen, International opioid consumption, Acta Anaesthesiologica Scandinavica, vol.48, issue.1, pp.162-167, 1997.
DOI : 10.1111/j.1399-6576.1997.tb04632.x

A. Ventes-de-médicaments-aux-officines-et-aux-hôpitaux-en-france, Disponible sur: http://ansm.sante.fr/S-informer/Presse- Communiques-Points-presse/L-Afssaps-met-en-ligne-les-chiffres-cles-2010-des-ventes- de-medicaments-ville-et-hopital, Communique, 2010.

M. Fontaine-adam, M. Daouphars, and J. Doucet, L'arrêt de commercialisation des médicaments contenant du dextropropoxyphène: quelles conséquences sur les prescriptions d'antalgiques, J Pharm Clin, vol.31, issue.1, pp.11-25, 2012.

F. Aubrun, Quel avenir pour les antalgiques de palier II. [Internet], Disponible sur, 2011.

. Afssaps, Prise en charge des douleurs de l'adulte moderees a intense - Recommandations après le retrait des associations contenant du dextropropoxyphene

L. Bachs, S. Skurtveit, and J. Mørland, Codeine and clinical impairment in samples in which morphine is not detected, European Journal of Clinical Pharmacology, vol.5, issue.12, pp.785-789, 2003.
DOI : 10.1007/s002280050491

T. Gibson, Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl, The American Journal of Medicine, vol.101, issue.1A, pp.47-53, 1996.
DOI : 10.1016/S0002-9343(96)00138-6

U. Stamer, F. Stüber, T. Muders, and F. Musshoff, Respiratory Depression with Tramadol in a Patient with Renal Impairment and CYP2D6 Gene Duplication, Anesthesia & Analgesia, vol.107, issue.3, pp.926-929, 2008.
DOI : 10.1213/ane.0b013e31817b796e

. Ministère-de-l-'intérieur, Bilan de l'accidentalité routière en 2012 [Internet]. 2013 Disponible sur: http://www.interieur.gouv.fr/Actualites/L-actu-du-Ministere/Bilan-de-l- accidentalite-routiere, 2012.

C. Mercier-guyon, Disponible sur: http://www.preventionroutiere.asso.fr/Nos-publications/Kit- Medecin 20. sécurité routière. Pour une conduite adaptée à sa santé. Médecins: Quel est votre rôle?, 2006.

R. Gonthier and S. Bonin-guillaume, Conduite automobile et sujet âgé: perspectives et rôles des médecins, Rev Gériatrie. nov, vol.37, issue.9, pp.695-699, 2012.

G. Mcgwin, R. Sims, L. Pulley, and J. Roseman, Relations among Chronic Medical Conditions, Medications, and Automobile Crashes in the Elderly: A Population-based Case-Control Study, American Journal of Epidemiology, vol.152, issue.5, pp.424-431, 2000.
DOI : 10.1093/aje/152.5.424

F. Barbone, A. Mcmahon, P. Davey, A. Morris, I. Reid et al., Association of road-traffic accidents with benzodiazepine use, The Lancet, vol.352, issue.9137, pp.1331-1336, 1998.
DOI : 10.1016/S0140-6736(98)04087-2

J. Verster, D. Veldhuijzen, and E. Volkerts, Residual effects of sleep medication on driving ability, Sleep Medicine Reviews, vol.8, issue.4, pp.309-325, 2004.
DOI : 10.1016/j.smrv.2004.02.001

W. Ray, R. Fought, and M. Decker, Psychoactive Drugs and the Risk of Injurious Motor Vehicle Crashes in Elderly Drivers, American Journal of Epidemiology, vol.136, issue.7, pp.873-883, 1992.
DOI : 10.1093/aje/136.7.873

S. Dubois, M. Bédard, and B. Weaver, The Impact of Benzodiazepines on Safe Driving, Traffic Injury Prevention, vol.12, issue.5, pp.404-413, 2008.
DOI : 10.1007/s001270200006

C. Neutel, Risk of traffic accident injury after a prescription for a benzodiazepine???, Annals of Epidemiology, vol.5, issue.3, pp.239-244, 1995.
DOI : 10.1016/1047-2797(94)00112-7

M. Linnoila and S. Häkkinen, Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving, Clinical Pharmacology & Therapeutics, vol.15, issue.4, pp.368-373, 1974.
DOI : 10.1002/cpt1974154368

L. Bachs, A. Engeland, J. Mørland, and S. Skurtveit, The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol, Clinical Pharmacology & Therapeutics, vol.25, issue.6, pp.596-599, 2009.
DOI : 10.1002/pds.1616

S. Dubois, M. Bédard, and B. Weaver, The association between opioid analgesics and unsafe driving actions preceding fatal crashes, Accident Analysis & Prevention, vol.42, issue.1, pp.30-37, 2010.
DOI : 10.1016/j.aap.2009.06.030

J. Zacny, K. Conley, and J. Galinkin, Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers, J Pharmacol Exp Ther. sept, vol.282, issue.3, pp.1187-1197, 1997.

A. Engeland, S. Skurtveit, and J. Mørland, Risk of Road Traffic Accidents Associated With the Prescription of Drugs: A Registry-Based Cohort Study, Annals of Epidemiology, vol.17, issue.8, pp.597-602, 2007.
DOI : 10.1016/j.annepidem.2007.03.009

K. Movig, M. Mathijssen, P. Nagel, T. Van-egmond, J. De-gier et al., Psychoactive substance use and the risk of motor vehicle accidents, Accident Analysis & Prevention, vol.36, issue.4, pp.631-636, 2004.
DOI : 10.1016/S0001-4575(03)00084-8

J. Zacny, Should people taking opioids for medical reasons be allowed to work and drive? Addict Abingdon Engl, nov, vol.91, issue.11, pp.1581-1584, 1996.

S. Leveille, D. Buchner, T. Koepsell, L. Mccloskey, M. Wolf et al., Psychoactive Medications and Injurious Motor Vehicle Collisions Involving Older Drivers, Epidemiology, vol.5, issue.6, pp.591-598, 1994.
DOI : 10.1097/00001648-199411000-00006

P. Mura, P. Kintz, B. Ludes, J. Gaulier, P. Marquet et al., Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study, Forensic Science International, vol.133, issue.1-2, pp.79-85, 2003.
DOI : 10.1016/S0379-0738(03)00052-5

S. Leung and . Benzodiazepines, Benzodiazepines, opioids and driving: An overview of the experimental research, Drug and Alcohol Review, vol.26, issue.4, pp.281-286, 2011.
DOI : 10.1111/j.1465-3362.2011.00311.x

H. Kress and B. Kraft, Opioid medication and driving ability, European Journal of Pain, vol.346, issue.2, pp.141-144, 2005.
DOI : 10.1016/j.ejpain.2004.05.010

D. Fishbain, R. Cutler, H. Rosomoff, and R. Rosomoff, Are Opioid-Dependent/Tolerant Patients Impaired in Driving-Related Skills? A Structured Evidence-Based Review, Journal of Pain and Symptom Management, vol.25, issue.6, pp.559-577, 2003.
DOI : 10.1016/S0885-3924(03)00176-3

G. Chesher, The influence of analgesic drugs in road crashes, Accident Analysis & Prevention, vol.17, issue.4, pp.303-309, 1985.
DOI : 10.1016/0001-4575(85)90031-4

J. Haythornthwaite, L. Menefee, A. Quatrano-piacentini, and M. Pappagallo, Outcome of Chronic Opioid Therapy for Non-Cancer Pain, Journal of Pain and Symptom Management, vol.15, issue.3, pp.185-194, 1998.
DOI : 10.1016/S0885-3924(97)00352-7

T. Galski, J. Williams, and H. Ehle, Effects of Opioids on Driving Ability, Journal of Pain and Symptom Management, vol.19, issue.3, pp.200-208, 2000.
DOI : 10.1016/S0885-3924(99)00158-X

D. Veldhuijzen, A. Van-wijck, F. Wille, J. Verster, J. Kenemans et al., Effect of chronic nonmalignant pain on highway driving performance, Pain, vol.122, issue.1, pp.28-35, 2006.
DOI : 10.1016/j.pain.2005.12.019

D. Walker and J. Zacny, Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers, Psychopharmacology, vol.140, issue.2, pp.191-201, 1998.
DOI : 10.1007/s002130050757

P. Sjøgren, A. Olsen, A. Thomsen, and J. Dalberg, Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status, Pain, vol.86, issue.3, pp.237-245, 2000.
DOI : 10.1016/S0304-3959(00)00248-7

H. Nilsen, N. Landrø, S. Kaasa, G. Jenssen, P. Fayers et al., Driving functions in a video simulator in chronic non-malignant pain patients using and not using codeine

J. Verster, D. Veldhuijzen, and E. Volkerts, Effects of an Opioid (Oxycodone/Paracetamol) and an NSAID (Bromfenac) on Driving Ability, Memory Functioning, Psychomotor Performance, Pupil Size, and Mood, The Clinical Journal of Pain, vol.22, issue.5, pp.499-504, 2006.
DOI : 10.1097/01.ajp.0000202981.28915.b2

J. Verster and M. Mets, Psychoactive Medication and Traffic Safety, International Journal of Environmental Research and Public Health, vol.6, issue.3, pp.1041-1054, 2009.
DOI : 10.3390/ijerph6031041

J. Lorenz, H. Beck, and B. Bromm, Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain, Pain, vol.73, issue.3, pp.369-375, 1997.
DOI : 10.1016/S0304-3959(97)00123-1

E. Lagarde, J. Chastang, S. Lafont, M. Coeuret-pellicer, and M. Chiron, Pain and pain treatment were associated with traffic accident involvement in a cohort of middle-aged workers, Journal of Clinical Epidemiology, vol.58, issue.5, pp.524-531, 2005.
DOI : 10.1016/j.jclinepi.2004.09.008

P. Sjogren, A. Thomsen, and A. Olsen, Impaired Neuropsychological Performance in Chronic Nonmalignant Pain Patients Receiving Long-Term Oral Opioid Therapy, Journal of Pain and Symptom Management, vol.19, issue.2, pp.100-108, 2000.
DOI : 10.1016/S0885-3924(99)00143-8

P. Marquet, P. Delpla, S. Kerguelen, J. Bremond, F. Facy et al., Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study, J Forensic Sci. juill, vol.43, issue.4, pp.806-811, 1998.

A. Christophersen and J. Mørland, Drugged driving, a review based on the experience in Norway, Drug and Alcohol Dependence, vol.47, issue.2, pp.125-135, 1997.
DOI : 10.1016/S0376-8716(97)00081-1

B. Smink, B. Ruiter, K. Lusthof, and P. Zweipfenning, Driving under the influence of alcohol and/or drugs in the Netherlands 1995???1998 in view of the German and Belgian legislation, Forensic Science International, vol.120, issue.3, pp.195-203, 2001.
DOI : 10.1016/S0379-0738(00)00476-X

C. Charlier and G. Plomteux, Alcohol, drugs, medication and highway safety in Belgium. Belgian Toxicology and Trauma Study Research Group. Rev Médicale Liège, janv, vol.53, issue.1, pp.25-28, 1998.

O. Drummer, J. Gerostamoulos, H. Batziris, M. Chu, J. Caplehorn et al., The incidence of drugs in drivers killed in Australian road traffic crashes, Forensic Science International, vol.134, issue.2-3, pp.2-3154, 2003.
DOI : 10.1016/S0379-0738(03)00134-8

O. Drummer, The role of drugs in road safety, Australian Prescriber, vol.31, issue.2, pp.33-35, 2008.
DOI : 10.18773/austprescr.2008.020

C. Ch-'ng, M. Fitzgerald, J. Gerostamoulos, P. Cameron, D. Bui et al., Drug use in motor vehicle drivers presenting to an Australian

I. Aubin-augier, A. Mercier, L. Baumann, A. Lehr-drylewicz, P. Imbert et al., Introduction à la recherche qualitative, Exercer, vol.19, issue.84, pp.142-145, 2008.

J. Borel, C. Deschaumes, L. Devoize, C. Huard, T. Orliaguet et al., Traitement de la douleur apr??s avulsion dentaire??: essai clinique randomis?? en double aveugle comparant deux formulations de parac??tamol, caf??ine et poudre d???opium versus tramadol et placebo, Presse Médicale, pp.103-111, 2010.
DOI : 10.1016/j.lpm.2009.09.025

N. Tavassoli, M. Lapeyre-mestre, A. Sommet, J. Montastruc, and F. , Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol), British Journal of Clinical Pharmacology, vol.47, issue.3, pp.422-426, 2009.
DOI : 10.1111/j.1365-2125.2009.03472.x

F. Müller, C. Odendaal, F. Müller, J. Raubenheimer, M. Middle et al., Comparison of the efficacy and tolerability of a paracetamol/codeine fixed-dose combination with tramadol in patients with refractory chronic back pain, Arzneimittelforschung. juin, vol.48, issue.6, pp.675-679, 1998.

H. Jeffrey, P. Charlton, D. Mellor, E. Moss, and M. Vucevic, Analgesia after intracranial surgery: a double-blind, prospective comparison of codeine and tramadol., British Journal of Anaesthesia, vol.83, issue.2, pp.245-249, 1999.
DOI : 10.1093/bja/83.2.245

I. Crighton, G. Hobbs, and I. Wrench, Analgesia after day case laparoscopic sterilisation#A comparison of tramadol with paracetamol/dextropropoxyphene and paracetamol/codeine combinations, Anaesthesia, vol.52, issue.7, pp.649-52, 1997.
DOI : 10.1111/j.1365-2044.1997.142-az0146.x

G. Pickering, M. Estrade, and C. Dubray, Comparative trial of tramadol/paracetamol and codeine/paracetamol combination tablets on the vigilance of healthy volunteers, Fundamental and Clinical Pharmacology, vol.81, issue.6, pp.707-711, 2005.
DOI : 10.1111/j.1532-5415.2004.52108.x

J. Fricke, . Jr, R. Karim, D. Jordan, and N. Rosenthal, A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery, Clinical Therapeutics, vol.24, issue.6, pp.953-968, 2002.
DOI : 10.1016/S0149-2918(02)80010-8

W. Mullican and J. Lacy, Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial, Clinical Therapeutics, vol.23, issue.9, pp.1429-1445, 2001.
DOI : 10.1016/S0149-2918(01)80118-1

M. Bourne, N. Rosenthal, J. Xiang, D. Jordan, and M. Kamin, Tramadol/acetaminophen tablets in the treatment of postsurgical orthopedic pain, Am J Orthop Belle Mead NJ. déc, vol.34, issue.12, pp.592-597, 2005.

A. Smith, T. Ravikumar, M. Kamin, D. Jordan, J. Xiang et al., Combination tramadol plus acetaminophen for postsurgical pain, The American Journal of Surgery, vol.187, issue.4, pp.521-527, 2004.
DOI : 10.1016/j.amjsurg.2003.12.038

A. Stubhaug, J. Grimstad, and H. Breivik, Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: a randomized, double-blind, placebo and standard active drug comparison, Pain, vol.62, issue.1, pp.111-118, 1995.
DOI : 10.1016/0304-3959(95)00056-X

N. Marie, M??canismes mol??culaires de la tol??rance aux opiac??s et aux cannabino??des, R??animation, vol.18, issue.7, pp.626-632, 2009.
DOI : 10.1016/j.reaurg.2009.06.016

M. Houle and M. Raymond, Opioides y dolor cr??nico no canceroso: desaf??os cl??nicos, Drogues, sant?? et soci??t??, vol.7, issue.1, p.357, 2008.
DOI : 10.7202/019626ar

H. Miranda and G. Pinardi, Antinociception, Tolerance, and Physical Dependence Comparison Between Morphine and Tramadol, Pharmacology Biochemistry and Behavior, vol.61, issue.4, pp.357-360, 1998.
DOI : 10.1016/S0091-3057(98)00123-3

W. Richter, H. Barth, L. Flohé, and H. Giertz, Clinical investigation on the development of dependence during oral therapy with tramadol, Arzneimittelforschung, vol.35, issue.11, pp.1742-1744, 1985.

A. Brinker, R. Bonnel, and J. Beitz, Abuse, Dependence, or Withdrawal Associated With Tramadol, American Journal of Psychiatry, vol.159, issue.5, pp.881-881, 2002.
DOI : 10.1176/appi.ajp.159.5.881

M. Tjäderborn, A. Jönsson, J. Ahlner, and S. Hägg, Tramadol dependence: a survey of spontaneously reported cases in Sweden, Pharmacoepidemiology and Drug Safety, vol.69, issue.132, pp.1192-1198, 2009.
DOI : 10.1002/pds.1838

E. Adams, R. Dart, J. Knisely, and S. Schnoll, Tramadol abuse and dependence among physicians, JAMA J Am Med Assoc. 27 avr, vol.293, issue.16, 1977.

A. Hall, J. Logan, R. Toblin, J. Kaplan, J. Kraner et al., Patterns of Abuse Among Unintentional Pharmaceutical Overdose Fatalities, JAMA, vol.300, issue.22, pp.2613-2620, 2008.
DOI : 10.1001/jama.2008.802

R. Escher, Antalgiques en automédication : quels sont les risques ? Douleur. 30 juin 2010, pp.1338-1341

L. Orriols, J. Gaillard, M. Lapeyre-mestre, and A. Roussin, Evaluation of Abuse and Dependence on Drugs Used for Self-Medication, Drug Safety, vol.369, issue.9572, pp.859-873, 2009.
DOI : 10.2165/11316590-000000000-00000

N. Attal, Traitement m??dicamenteux des douleurs neuropathiques, La Presse M??dicale, vol.37, issue.2, pp.346-353, 2008.
DOI : 10.1016/j.lpm.2007.07.023

M. Espié, Le suivi du patient cancéreux, John Libbey Eurotext, 2001.

S. Sindrup, G. Andersen, C. Madsen, T. Smith, K. Brøsen et al., Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial, Pain, vol.83, issue.1, pp.85-90, 1999.
DOI : 10.1016/S0304-3959(99)00079-2

Y. Harati, C. Gooch, M. Swenson, S. Edelman, D. Greene et al., Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy, Neurology, vol.50, issue.6, pp.1842-1846, 1998.
DOI : 10.1212/WNL.50.6.1842

R. Tyndale, K. Droll, and E. Sellers, Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence, Pharmacogenetics, vol.7, issue.5, pp.375-379, 1997.
DOI : 10.1097/00008571-199710000-00006

R. Helme and S. Gibson, The epidemiology of pain in elderly people, Clinics in Geriatric Medicine, vol.17, issue.3, pp.417-431, 2001.
DOI : 10.1016/S0749-0690(05)70078-1

G. Pickering, Pharmacologie de la douleur chez la personne âgée, Psychol Neuropsychiatr Vieil. 1 juin, vol.4, issue.2, pp.95-102, 2006.

P. Wotquenne, J. Petermans, and A. Scheen, La prescription médicamenteuse chez la personne âgée: que devons nous savoir? Rev Médicale Suisse, pp.1878-80, 2006.

B. Diquet and P. Lainé-cessac, Recherche d'un terrain à risque et adaptation thérapeutique. Interactions médicamenteuses, Rev Prat. 15 mars, vol.55, issue.5, pp.541-545, 2005.

A. Scheen, Interactions médicamenteuses : De la théorie à la pratique, RMLG Rev Médicale Liège, vol.61, pp.5-6471

M. Miller, T. Stürmer, D. Azrael, R. Levin, and D. Solomon, Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis, Journal of the American Geriatrics Society, vol.57, issue.3, pp.430-438, 2011.
DOI : 10.1111/j.1532-5415.2011.03318.x

Z. Guo, P. Wills, M. Viitanen, J. Fastbom, and B. Winblad, Cognitive Impairment, Drug Use, and the Risk of Hip Fracture in Persons over 75 Years Old: A Community-based Prospective Study, American Journal of Epidemiology, vol.148, issue.9, pp.887-892, 1998.
DOI : 10.1093/oxfordjournals.aje.a009714

R. Shorr, M. Griffin, J. Daugherty, and W. Ray, Opioid Analgesics and the Risk of Hip Fracture in the Elderly: Codeine and Propoxyphene, Journal of Gerontology, vol.47, issue.4, pp.111-115, 1992.
DOI : 10.1093/geronj/47.4.M111

J. Hubert, Dans les grandes agglomérations, la mobilité quotidienne des habitants diminue, et elle augmente ailleurs Insee Première Disponible sur, 1252.

E. Kelly, S. Darke, and R. J. , A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions, Drug and Alcohol Review, vol.23, issue.3, pp.319-344, 2004.
DOI : 10.1080/09595230412331289482

J. Kerr and I. Hindmarch, The effects of alcohol alone or in combination with other drugs on information processing, task performance and subjective responses, Human Psychopharmacology: Clinical and Experimental, vol.105, issue.1, pp.1-9, 1998.
DOI : 10.1002/(SICI)1099-1077(199801)13:1<1::AID-HUP939>3.0.CO;2-0

M. Byas-smith, S. Chapman, B. Reed, and G. Cotsonis, The Effect of Opioids on Driving and Psychomotor Performance in Patients With Chronic Pain, The Clinical Journal of Pain, vol.21, issue.4, pp.345-352, 2005.
DOI : 10.1097/01.ajp.0000125244.29279.c1

C. Charlier, La législation relative à la détection des médicaments

J. Alvarez, D. Gier, and J. , International Council on Alcohol D. Prescribing and dispensing guidelines for medicinal drugs affecting driving performance. [Mississippi State, 2001.

D. Carra, Niveau de connaissance des effets des médicaments sur la conduite d'engins chez les usagers et les professionnels de santé et impact des pictogrammes sur leur comportement, Thèse], 2010.

F. Dubois, Médicaments à risque pour la conduite automobile : évaluation de l'impact des pictogrammes auprès de patients, de médecins généralistes et de pharmaciens, 2007.

J. Zacny, A review of the effects of opioids on psychomotor and cognitive functioning in humans., Experimental and Clinical Psychopharmacology, vol.3, issue.4, pp.432-466, 1995.
DOI : 10.1037/1064-1297.3.4.432

J. Amato, Étude des effets de différentes doses de l'association paracétamol et codéine sur les comportements de conduite automobile de sujets jeunes Institut national de recherche sur les transports et leur sécurité, Disponible sur, 2010.

N. Lelièvre, Conducteur à risque et secret médical Douleurs Eval -Diagn -Trait, févr, vol.10, issue.1, pp.48-52, 2009.

H. Autorité and D. Santé, Délivrance de l'information à la personne sur son état de santé [Internet]. 2012 [cité 5 sept 2013]. Disponible sur

C. Keown, P. Slovic, and S. Lichtenstein, Attitudes of physicians, pharmacists, and laypersons toward seriousness and need for disclosure of prescription drug side effects., Health Psychology, vol.3, issue.1, pp.1-11, 1984.
DOI : 10.1037/0278-6133.3.1.1

B. Ventelou and R. S. , ??valuation de l'implication des m??decins g??n??ralistes lib??raux dans le bon usage des m??dicaments, Sant?? Publique, vol.21, issue.2, pp.129-138, 2009.
DOI : 10.3917/spub.092.0129

J. Berthelot, J. Glemarec, P. Guillot, A. Chiffoleau, Y. Maugars et al., Informing patients about serious side effects of drugs. A 2001 survey of 341 French rheumatologists, Joint Bone Spine, vol.70, issue.1, pp.52-57, 2003.
DOI : 10.1016/S1297-319X(02)00011-8

D. Roter and J. Hall, Doctors Talking with Patients/patients Talking with Doctors: Improving Communication in Medical Visits, 1992.

F. Stevenson, The strategies used by general practitioners when providing information about medicines, Patient Education and Counseling, vol.43, issue.1, pp.97-104, 2001.
DOI : 10.1016/S0738-3991(00)00154-3

J. Katz, L. Daltroy, T. Brennan, and M. Liang, Informed consent and the prescription of nonsteroidal antiinflammatory drugs, Arthritis & Rheumatism, vol.143, issue.11, pp.1257-1263, 1992.
DOI : 10.1002/art.1780351103

B. Le, Dossier observance, Rev Prat Médecine Générale, vol.13, issue.469, pp.1335-1383, 1999.

. Peck and . Kn, Comment améliorer l'observance des malades vis à vis des prescriptions, JAMA Paris, vol.7, issue.66, pp.203-208, 1983.

J. Mcgrath, Physicians' Perspectives on Communicating Prescription Drug Information, Qualitative Health Research, vol.9, issue.6, pp.731-745, 1999.
DOI : 10.1177/104973299129122243

G. Lamb, S. Green, and J. Heron, Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med, 12 déc, vol.154, issue.23, pp.2753-2756, 1994.

W. Ha and L. A. , Patient awareness of the adverse effects of non-steroidal antiinflammatory drugs (NSAIDs), Br J Clin Pharmacol. août, vol.42, issue.2, pp.253-256, 1996.

M. Conduite, Etes-vous sensibilisé au problème des effets des médicaments sur la conduite automobile ? Si oui pour quels médicaments et par quel moyen ? -En informez-vous vos patients systématiquement ? (pourquoi ?) -Que pensez-vous de l'information lors de la prescription ? Par quels moyens ou personnes devrait se faire l'information des patients, à votre avis?